期刊
JOURNAL OF MEDICINAL CHEMISTRY
卷 49, 期 21, 页码 6139-6142出版社
AMER CHEMICAL SOC
DOI: 10.1021/jm060460o
关键词
-
资金
- NCI NIH HHS [U19CA113317] Funding Source: Medline
A structure-based approach was employed to design a new class of small-molecule inhibitors of Bcl-2. The most potent compound 5 (TW-37) binds to Bcl-2 with a K-i value of 290 nM and also to BclxL and Mcl-1 with high affinities. Compound 5 potently inhibits cell growth in PC-3 prostate cancer cells with an IC50 value of 200 nM and effectively induces apoptosis in a dose-dependent manner.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据